Analysis of Gait Before and After Botulinum Toxin Treatment in Patients With Focal Dystonia
Status:
Recruiting
Trial end date:
2023-10-23
Target enrollment:
Participant gender:
Summary
Efficient gait requires effective postural control, both static and dynamic. Hence, postural
disorders may affect gait. Yet, very little is known about the specific effects of focal
postural disorders such as cervical dystonia (CD) and blepharospasm (BS) on patients'
mobility.
The present research therefore aims at analyzing gait characteristics in patients presenting
with these conditions in order to document possible gait alterations.
In addition, the investigators will explore the effect of botulinum toxin treatment, which
the most frequently used therapeutic option, on the patients' gait characteristics. Indeed,
while the treatment improves both dystonia and pain, and therefore quality of life, its
influence on gait is presently unknown. the investigators aim at filling this knowledge gap